• Title/Summary/Keyword: Gastric secretion.

Search Result 197, Processing Time 0.022 seconds

General Pharmacological Action of Prophylactic Bioactive Materials (예방의학적 생리활성물질의 일반약리작용)

  • Jung, Ki-Hwa
    • Journal of Food Hygiene and Safety
    • /
    • v.18 no.4
    • /
    • pp.171-176
    • /
    • 2003
  • In the study of general pharmacological action, we tested effect on spontaneous momentum, phenobarbital sleeping times, secretion of gastric juice, body temperature and movement of small intestine, etc. Using Pleurospermum kamtschaticum, Angelica tenuissima, Angelica gigas and Zanthoxylum schinifolium as samples to estimate adverse effects. In the study of general pharmacological action to estimate adverse effects, we observed no side effects of sample-treated groups against the control group.

General Pharmacological Properties of DKY, an Antidiabetic Oriental Drug Preparation (항당뇨 천연물 복합신약 DKY의 일반약리작용)

  • 이은방;조성익;이대위;현진이
    • Biomolecules & Therapeutics
    • /
    • v.9 no.3
    • /
    • pp.224-230
    • /
    • 2001
  • DKY is an oriental drug preparation composed of 17 natural products and is known to have antihyperglycemic action at 100 mg/kg po in animal tests. The general pharmacological properties of DKY preparation were investigate in mice, rats, guinea pigs and rabbits. This preparation did neither show any effects on central nervous system, nor effects on algesia, nor epilepsia at the large doses of 3000 mg/kg po in mice or rats. However, the preparation showed hypothermic action at the doses of 330 and 1000 mg/kg po. In the guinea pig ileum, rat fundus strip and estrogenized rat uterus, DKY did not influence their tension at a concentration of 3$\times$10$^{-3}$ g/ml, and the spasmogenic actions produced by histamine, ACh and 5-HT were not blocked in the presence of DKY at 3$\times$10$^{-3}$ g/ml. The blood pressure and respiration were not considerably influenced at 10 mg/kg iv of DKY in rabbits. It did not influence the intestinal propulsion of mice and the normal gastric secretion of rats. These results may suggest that DKY preparation have little effects on central nervous, autonomic and gastrointestimal systems, except hypothermic action.

  • PDF

Analysis of the concept of body fluid in "Hwangjenaegyeong(黃帝內經)" ($\ll$황제내경(黄帝内经)$\gg$ "진액(津液)" 개념고변(概念考辨))

  • Feng, Gu;Kim, Hyo-Chul
    • Journal of Korean Medical classics
    • /
    • v.23 no.1
    • /
    • pp.11-13
    • /
    • 2010
  • In this article, the concept of body fluid is explained in three aspects: the word meaning of body fluid, the origins of the definitions of the body fluid concept and the connotation and extension of body fluid. Investigating data about the time Hwangjenaegyeong(黃帝內經) was written, the author discovers that the meaning of "Aek(液)" is clear, but there are still questions about the meaning of "Jin(津)". The concept of body fluid derived from observation of life phenomenon and ancient philosophy on the "water". The concept of body fluid should be expressed as that body fluid is a general term for all normal liquids in the body. Within the meridians, as the composition of blood components; outside the meridians, constituting the intrinsic body fluids of various organs and tissues. This is the main part of body fluid, coming from diet, constituting the human body and maintaining human life activities, playing the roles of moistening and nourishing various of organs and tissues of the body. In addition, Interstitial fluid, all kinds of normal liquid secretion and metabolic products, such as sweat, tears, nasal discharge, saliva, slobber, gastric juice, intestinal fluid, urine, joint fluid, latex and so on, both belong to body fluid.

General Pharmacology of G(7-rhEPO\ulcorner a New Recombinant Ruman Erythropoietin (유전자 재조합 사람 erythropoietin, GC-rhEPO의 일반약리작용)

  • 한성규;김선돈;정원휘;이호성;김성남;백대현;허재욱;성연희;류판동
    • Biomolecules & Therapeutics
    • /
    • v.8 no.2
    • /
    • pp.184-193
    • /
    • 2000
  • To evaluate GC-rhEPO, human erythropoietin produced by recombinant DNA technique, its general pharmacological properties were investigated in experimental animals administering intravenously and in vitro test system. GC-rhEPO at doses of 70,700 and 7,000 IU/kg body weight had no influence on general behavior, spontaneous motor activity, thiopental-inducted sleeping time, writhing syndrome induced by acetic acid, strychnine-induced convulsions, charchoal meal propulsion in mice, and body temperature, gastric juice secretion, urine and electrolyte excretion in rats. In anesthetized rabbits, GC-rhEPO (70, 700 and 7,000 lU/kg, i.v.) did not alter respiratory rate, blood pressure, heat rate. In in vitro experiments, GC-rhEPO did not affect the contractions of the isolated ileum of guinea pigs and the muscle twitchs of isolated neuromuscular junction of the rats. In addition, GC-rhEPO did not affect the blood coagulation time and ADP-induced platelet aggregation in plasma of rabbits. Taken together, these results indicate that GC-rhEPO does not induce any adverse effects in the experimental animals.

  • PDF

General Pharmacology of Urinary Trypsin Inhibitor (UTI) (Urinary Trypsin Inhibitor (UTI)의 일반약리작용)

  • 성연희;조순옥;이선애;임화경;장춘곤;김학성;강종구
    • Biomolecules & Therapeutics
    • /
    • v.4 no.4
    • /
    • pp.385-390
    • /
    • 1996
  • General pharmacological properties of urinary trypsin inhibitor (UTI) following intravenous administration of 1,000,000 units/kg were examined in terms of effects on central nervous system, cardiovascular system, respiratory system, gastrointestinal system in mice, rats and rabbits. Administration of UTI (1,000,000 units/kg, iv) had no effect on central nervous system; no influences on pentobarbital sleeping time, spontaneous activity, normal body temperature, chemoshock produced by pentylenetetrazole solution, writhing syndromes induced by 0.6% acetic acid solution, and motor coordination of mice. The administration of UTI (1,000,000) units/kg, iv) in rats had no effect on systolic blood pressure and pulse rate. UTI (500,000 units/kg, iv) given to anesthetized rabbits showed no effect on respiratory rate. However, it showed significant elevation of respiratory rate at the concentration of 1,000,000 units/kg. Gastric secretion of rat and intestinal motility of mice were not influenced by the dose of 1,000,000 units/kg. In terms of autonomic nervous system, the material did not show direct effect and inhibitory or augmentative action of histamine- or acetylcholine-induced contraction at the concentration of 2,000 units/ml in the isolated ileum of guinea pig.

  • PDF

Effect of the Rosa rugosa Extract on the Rat with the Alcohol-salicylate-induced Gastropathy (위액분비 및 실험적 위손상에 대한 해당근 엑기스의 효과)

  • Park, Hee-Juhn;Lim, Sang-Cheol;Kim, Dong-Hoon;Lee, Jeung-Hee;Kang, He-Ok;Choi, Jong-Won
    • Korean Journal of Pharmacognosy
    • /
    • v.36 no.1 s.140
    • /
    • pp.38-43
    • /
    • 2005
  • This study was undertaken to evaluate the gastrotherapeutic effects of the extract of Rosa rugosa. It can be regarded that the antigastric and anti-ulcerative effect of Rosa rugosa is originated from the reduction of total acid output identified by gastric secretion test. To clarify the protective mechanism of the Rosa rugosa extract, the gastropathy was induced in rats with alcohol-salicylate and the activities of the free radical scavenging enzymes were examined. The acitivity of superoxide dismutase and glutathione peroxide were significantly increased and the total content of glutathione was recovered. We concluded that the protective effect of the extract of Rosa rugosa on gastropathy in rats is its ability increased the activities of the free radical scavenging enzymes.

General Pharmacology of AG 60, a New Anticancer Drug (새로운 항암제 AG 60의 일반약리작용)

  • 성연희;안희열;김선돈;이선애;조순옥;한영복
    • Biomolecules & Therapeutics
    • /
    • v.5 no.4
    • /
    • pp.412-418
    • /
    • 1997
  • General pharmacological properties of AG 60 (mixture of acriflavine and guanosine (1:1, w/w)), which has anticancer effect, following intramuscular administration were examined in terms of effects on central nervous system, gastrointestinal system, cardiovascular system, respiratory system and autonomic nervous system in mice, rats, guinea-pigs and rabbits. AG 60 at the dose of 15 mgtg had no influences on pentobarbital sleeping time, spontaneous motor activity, chemoshock produced by pentylenetetrazole solution, writhing syndromes induced by 0.8% acetic acid solution, and motor coordination of mice. However, AG 60 at the dose of 7.5 and 15 mg/kg caused significant decrease of normal body temperature 1 and/or 2 h after the administration. No influence on body temperature was observed at 3.75 mg/kg in mice. Gastric secretion of rat and intestinal motility of mice were not influenced by the dose of 15 mg/kg. In terms of autonomic nervous system, AG 60 did not show direct effect and inhibitory or augmentative action of histamine- or acetylcholine-induced contractions at the concentration of 5 mg/L in the isolated ileum of guinea-pig. The administration of 15 mg/kg of AG 60 did not affect mean arterial blood pressure and heart rate in rat. AG 60 (15 mg/kg) given to anesthetized rabbits showed no effect on respiratory rate.

  • PDF

A review of Spice Phenomenon Therapy (향신(香身)요법에 관한 문헌 고찰)

  • Lee, Seung-Ho;Park, Pil-Sang;Kwon, Dong-Yeul
    • Herbal Formula Science
    • /
    • v.18 no.2
    • /
    • pp.15-23
    • /
    • 2010
  • The spice phenomenon therapy is to adhibit aromatic herbs or materials to the human body or clothing, for the purpose of preventing and treating diseases. Mankind found the fire, and found that some plants and trees give off smoke when they are burning. Then, they found that some of aromatic substances had certain actions after being absorbed through the respiratory organ, which was the beginning of the spice phenomenon therapy. The spice phenomenon therapy is effective to relieve the exterior syndrome, to eliminate dampness, to regulate Qi flow, and to induce resuscitation. It has two actions. One is that the aromas that permeated the body, refreshes the mind, stimulates the appetite, strengthens the spleen and the stomach, and makes a relaxing sleep. The other is that the aromatic substances, absorbed into the human body, have pharmacological actions. The volatile aromatic substances have various pharmacological actions such as stimulating cranial nerves, dilating cardiac blood vessels, promoting gastric secretion, relaxing and sleep-inducing. It has been proved that the spice phenomenon therapy is anti-inflammatory and anti-microbial and is effective to dilate cerebral blood vessels and to ease the pain. It is expected to be studied more aggressively.

Transformation Techniques for the Large Scale Production of Ginsenoside Rg3 (Ginsenoside Rg3의 함량증가를 위한 변환 기술)

  • Nam, Ki Yeul;Choi, Jae Eul;Park, Jong Dae
    • Korean Journal of Medicinal Crop Science
    • /
    • v.21 no.5
    • /
    • pp.401-414
    • /
    • 2013
  • Ginsenoside Rg3 (G-Rg3) contained only in red ginseng has been found to show various pharmacological effects such as an anticancer, antiangiogenetic, antimetastastic, liver protective, neuroprotective immunomodulating, vasorelaxative, antidiabetic, insulin secretion promoting and antioxidant activities. It is well known that G-Rg3 could be divided into 20(R)-Rg3 and 20(S)-Rg3 according to the hydroxyl group attached to C-20 of aglycone, whose structural characteristics show different pharmacological activities. It has been reported that G-Rg3 is metabolized to G-Rh2 and protopanaxadiol by the conditions of the gastric acid or intestinal bacteria, thereby these metabolites could be absorbed, suggesting its absolute bioavailability (2.63%) to be very low. Therefore, we reviewed the chemical, physical and biological transformation methods for the production on a large scale of G-Rg3 with various pharmacological effects. We also examined the influence of acid and heat treatment-induced potentials on for the preparation method of higher G-Rg3 content in ginseng and ginseng products. Futhermore, the microbial and enzymatic bio-conversion technologies could be more efficient in terms of high selectivity, efficiency and productivity. The present review discusses the available technologies for G-Rg3 production on a large scale using chemical and biological transformation.

General Pharmacology of Recombinant Erythropoietin (LB-00014) (유전자 재조합 Erythropoietin (LB-00014)의 일반약리작용)

  • 이은방;이향주;천선아;조성익;손지영
    • Biomolecules & Therapeutics
    • /
    • v.4 no.2
    • /
    • pp.154-161
    • /
    • 1996
  • General pharmacological properties of LB-00014, an erythropoietin which was produced by recombinant DNA technique in Biotech Research Institute, LG Chemical Ltd. were examined. The administration of LB-00014 (60, 600, 6000 IU/kg, iv) in mice had no effect in general behavior and central nervous system, and no influences on normal body temperature, writhing syndromes induced by 0.7% acetic acid solution and chemoshock produced by strychnine and pentetrazole solution. LB-00014 (60, 600, 6000 IU/kg, iv) given to anesthetized rabbits showed no effect on blood pressure of carotid artery and respiration rates, and it did not influence the responses produced by injection of acetylcholine or epinephme. The administration of LB-00014 (601, 600, 6000 IU/kg, iv) in rats had no effect on the plasma prothrombin time, activated partial thromboplastin time and hemolytic action. The platelet aggregation induced by collagen in human plasma was not influenced by LB-00014 (10, 100, 1000 lU/kg, iv). It showed no direct effect at 100 and 1000IU/m1 in isolated stomach fundus and uterus of rats and ileum of guinea-pig, and it also had no inhibition of contraction produced by acetylcholine, oxytocin, serotonin and histamine in the above-mentioned preparations. It did not influence gastric secretion, pH and acid output at 6000 IU/kg, iv in rats, but showed a significant increase in intestinal propulsion of mice at 6000 IU/kg, iv. Its administration (60, 600, 6000 lU/kg, iv) caused no effect on urine and electrolyte excretion in rats. These results indicate that LB-00014 does not exsert any of serious pharmacological effects.

  • PDF